The mismatch repair (MMR) system has a key role in supporting the DNA polymerase proofreading function and in maintaining genome stability. Alterations in the MMR genes are driving events of tumorigenesis, tumor progression, and resistance to therapy. These genetic scars may occur in either hereditary or sporadic settings, with different frequencies across tumor types. Appropriate characterization of the MMR status is a crucial task in oncologic pathology because it allows for both the tailored clinical management of cancer patients and surveillance of individuals at risk. The currently available MMR testing methods have specific strengths and weaknesses, and their application across different tumor types would require a tailored approach. This article highlights the indications and challenges in MMR status assessment for molecular pathologists, focusing on the possible strategies to overcome analytical and pre-analytical issues.
Mismatch Repair Status Characterization in Oncologic Pathology : Taking Stock of the Real-World Possibilities / R. Piciotti, K. Venetis, E. Sajjadi, N. Fusco. - In: JOURNAL OF MOLECULAR PATHOLOGY. - ISSN 2673-5261. - 2:2(2021 Apr), pp. 93-100. [10.3390/jmp2020009]
Mismatch Repair Status Characterization in Oncologic Pathology : Taking Stock of the Real-World Possibilities
R. PiciottiPrimo
;K. Venetis;E. Sajjadi;N. Fusco
Ultimo
2021
Abstract
The mismatch repair (MMR) system has a key role in supporting the DNA polymerase proofreading function and in maintaining genome stability. Alterations in the MMR genes are driving events of tumorigenesis, tumor progression, and resistance to therapy. These genetic scars may occur in either hereditary or sporadic settings, with different frequencies across tumor types. Appropriate characterization of the MMR status is a crucial task in oncologic pathology because it allows for both the tailored clinical management of cancer patients and surveillance of individuals at risk. The currently available MMR testing methods have specific strengths and weaknesses, and their application across different tumor types would require a tailored approach. This article highlights the indications and challenges in MMR status assessment for molecular pathologists, focusing on the possible strategies to overcome analytical and pre-analytical issues.File | Dimensione | Formato | |
---|---|---|---|
[2021] jmp-02-00009 (1).pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
244.87 kB
Formato
Adobe PDF
|
244.87 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.